FPRX
UBS Group’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-56,930
| Closed | -$2.14M | – | 9101 |
|
2021
Q1 | $2.14M | Buy |
56,930
+50,932
| +849% | +$1.92M | ﹤0.01% | 2706 |
|
2020
Q4 | $102K | Buy |
5,998
+1,768
| +42% | +$30.1K | ﹤0.01% | 4694 |
|
2020
Q3 | $19K | Sell |
4,230
-54,317
| -93% | -$244K | ﹤0.01% | 5502 |
|
2020
Q2 | $357K | Buy |
58,547
+37,531
| +179% | +$229K | ﹤0.01% | 3620 |
|
2020
Q1 | $48K | Sell |
21,016
-29,990
| -59% | -$68.5K | ﹤0.01% | 4986 |
|
2019
Q4 | $234K | Sell |
51,006
-68,207
| -57% | -$313K | ﹤0.01% | 4505 |
|
2019
Q3 | $462K | Buy |
119,213
+117,135
| +5,637% | +$454K | ﹤0.01% | 3789 |
|
2019
Q2 | $12K | Sell |
2,078
-776
| -27% | -$4.48K | ﹤0.01% | 6102 |
|
2019
Q1 | $39K | Sell |
2,854
-96,584
| -97% | -$1.32M | ﹤0.01% | 4921 |
|
2018
Q4 | $925K | Buy |
99,438
+90,954
| +1,072% | +$846K | ﹤0.01% | 3048 |
|
2018
Q3 | $118K | Buy |
8,484
+1,927
| +29% | +$26.8K | ﹤0.01% | 4596 |
|
2018
Q2 | $104K | Sell |
6,557
-92,096
| -93% | -$1.46M | ﹤0.01% | 4538 |
|
2018
Q1 | $1.7M | Buy |
98,653
+87,363
| +774% | +$1.5M | ﹤0.01% | 2662 |
|
2017
Q4 | $248K | Buy |
11,290
+4,126
| +58% | +$90.6K | ﹤0.01% | 3882 |
|
2017
Q3 | $293K | Sell |
7,164
-512
| -7% | -$20.9K | ﹤0.01% | 3776 |
|
2017
Q2 | $231K | Buy |
7,676
+1,604
| +26% | +$48.3K | ﹤0.01% | 3823 |
|
2017
Q1 | $220K | Sell |
6,072
-15,986
| -72% | -$579K | ﹤0.01% | 3774 |
|
2016
Q4 | $1.11M | Buy |
22,058
+7,170
| +48% | +$359K | ﹤0.01% | 2740 |
|
2016
Q3 | $782K | Buy |
14,888
+13,086
| +726% | +$687K | ﹤0.01% | 2880 |
|
2016
Q2 | $75K | Buy |
1,802
+987
| +121% | +$41.1K | ﹤0.01% | 4391 |
|
2016
Q1 | $33K | Sell |
815
-61
| -7% | -$2.47K | ﹤0.01% | 5012 |
|
2015
Q4 | $37K | Buy |
+876
| New | +$37K | ﹤0.01% | 5019 |
|
2015
Q3 | – | Sell |
-898
| Closed | -$22K | – | 7023 |
|
2015
Q2 | $22K | Buy |
+898
| New | +$22K | ﹤0.01% | 5432 |
|